NOVOSIBIRSK (Sputnik): Russia has completed phase 2 clinical trials of its single-dose coronavirus vaccine Sputnik Light, all data has been submitted to experts for assessment, Health Minister Mikhail Murashko said on Friday.
“Phase 2 clinical trials have been completed. [Information] has been submitted for expert assessment. We have also completed the assessment of [Russian research center] Vector’s EpiVacCorona vaccine for people aged 60 years and over,” Murashko told reporters.
